The GAVI Alliance said it will now include HPV and combined measles-rubella vaccines in its portfolio for the first time as it opens a new round of applications for support from eligible countries. GAVI Alliance Board Chair Dagfinn Høybråten commented, “Making it possible for children and women in developing countries to have the same access to these life-saving vaccines as their counterparts in richer nations is what GAVI was created to do. By opening this new application round, we take another step towards our goal to avert close to four million future deaths by 2015 through immunisation. Ours is an investment that helps build healthy communities and accelerates development.”

http://www.gavialliance.org/library/news/press-releases/2012/new-vaccine-support-against-cervical-cancer-rubella/